Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 10/20 | 0.67 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.49 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28201063 | 0.98 | GAA (0.65) | GAAALOX5CYP3A4TSHRLMNA | |
| SCHEMBL28080824 | 0.81 | GAA (0.59) | GAAALOX5CYP3A4TSHRSMN1; SMN2 | |
| SCHEMBL2232787 | 0.81 | GAA (0.56) | GAACYP3A4LMNAHTTSMN1; SMN2 | |
| SCHEMBL11717808 | 0.80 | GAA (0.70) | GAAALOX5CYP3A4TSHRLMNA | |
| SCHEMBL4254852 | 0.80 | GAA (0.60) | GAAALOX5CYP3A4TSHRLMNA | |
| SCHEMBL2234441 | 0.80 | GAA (1.00) | GAAALOX5CYP3A4TSHRLMNA | |
| SCHEMBL11781508 | 0.79 | GAA (0.69) | GAAALOX5CYP3A4TSHRLMNA | |
| SCHEMBL9553582 | 0.79 | GAA (0.58) | GAAALOX5CYP3A4TSHRLMNA | |
| SCHEMBL2237027 | 0.79 | PTGS2 (0.58) | GAACYP3A4LMNASMN1; SMN2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28240039 | 0.79 | GAA (0.96) | GAAALOX5CYP3A4TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112481319-A | Green synthesis method of carbamate | 中国科学院青岛生物能源与过程研究所 | 2021-03-12 | — | — | CN | disclosed |
| CN-102186811-B | Process for producing bisoxazolinone compound and intermediate thereof | SUMITOMO CO LTD | 2013-07-24 | — | — | CN | disclosed |
| US-8299264-B2 | Method for producing oxadiazolinone compound and intermediate thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-30 | — | — | US | disclosed |
| CN-102186811-A | Process for producing bisoxazolinone compound and intermediate thereof | SUMITOMO CHEMICAL CO | 2011-09-14 | — | — | CN | disclosed |
| US-20110207936-A1 | METHOD FOR PRODUCING OXADIAZOLINONE COMPOUND AND INTERMEDIATE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-08-25 | — | — | US | disclosed |
| EP-2357167-A1 | METHOD FOR PRODUCING OXADIAZOLINONE COMPOUND AND INTERMEDIATE THEREOF | Sumitomo Chemical Company, Limited (JP) | 2011-08-17 | — | — | EP | disclosed |
| CN-1303043-C | Process for producing biaryl compound | SUMITOMO CHEMICAL CO (JP) | 2007-03-07 | — | — | CN | disclosed |
| CN-1642879-A | Process for preparing diaryl compounds | SUMITOMO CHEMICAL CO (JP) | 2005-07-20 | — | — | CN | disclosed |
| CN-1226891-A | Processes for preparing indeno [1,2-E] (1,3,4) oxadiazine-dicarboxylates | DU PONT (US) | 1999-08-25 | — | — | CN | disclosed |
| CN-1043766-C | Indole derivative and preparation and pharmaceutical using of same | TORAY INDUSTRIES (JP) | 1999-06-23 | — | — | CN | disclosed |
| CN-1092425-A | Indole derivatives, its manufacture method and medicinal use thereof | TORAY INDUSTRIES (JP) | 1994-09-21 | — | — | CN | disclosed |
| US-4036824-A | Disazo dyestuffs containing A-O-alkylene-O-SO3 H group | BAYER AKTIENGESELLSCHAFT (DT) | 1977-07-19 | — | — | US | disclosed |
| US-4018814-A | ANTHELMINTICS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-04-19 | — | — | US | disclosed |
| US-4013676-A | NEMATOCIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-03-22 | — | — | US | disclosed |
| US-3996247-A | ANTHELMINTIC | BAYER AKTIENGESELLSCHAFT (DT) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207936-A1 | METHOD FOR PRODUCING OXADIAZOLINONE COMPOUND AND INTERMEDIATE THEREOF | AHR, CYP1B1, AR | GAA 4157/4885ALOX5 789/4885CYP3A4 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.